Endothelin-1 Augments Na+/H+ Exchange Activity in Murine Pulmonary Arterial Smooth Muscle Cells via Rho Kinase

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Undem, Clark ^a   Rios, Eon J ^a   Maylor, Julie ^a   Shimoda, Larissa A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; PROTEIN KINASE C; PROTON; RHO KINASE; RHO KINASE INHIBITOR; SODIUM ION;

ANIMAL CELL; ARTICLE; BREATHING MUSCLE; CELL GROWTH; CELL PH; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTON SODIUM EXCHANGE; PULMONARY ARTERY; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME ACTIVATION; FLUORESCEINS; FLUORESCENT DYES; HYDROGEN-ION CONCENTRATION; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PULMONARY ARTERY; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

MURINAE; RATTUS;

EID: 84866995187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046303     Document Type: Article

References (70)

1. Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, et al. (2009) Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 54: S32-42.
2. Davies RJ, Morrell NW, (2008) Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest. 134: 1271-7.
3. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, et al. (1996) Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 335: 609-16.
4. Bobik A, Grooms A, Little PJ, Cragoe EJ Jr, Grinpukel S, (1991) Ethylisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth. Am J Physiol. 260: C581-8.
5. LaPointe MS, Batlle DC, (1994) Na+/H+ exchange and vascular smooth muscle proliferation. Am J Med Sci. 307Suppl 1: S9-16.
6. Mitsuka M, Nagae M, Berk BC, (1993) Na+-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation. Circ Res. 73: 269-75.
7. Quinn DA, Dahlberg CG, Bonventre JP, Scheid CR, Honeyman T, et al. (1996) The role of Na+/H+ exchange and growth factors in pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol. 14: 139-45.
8. Aalkjaer C, Cragoe EJ Jr, (1988) Intracellular pH regulation in resting and contracting segments of rat mesenteric resistance vessels. J Physiol. 402: 391-410.
9. Aalkjaer C, Peng HL, (1997) pH and smooth muscle. Acta Physiol Scand. 161: 557-66.
10. Madden JA, Ray DE, Keller PA, Kleinman JG, (2001) Ion exchange activity in pulmonary artery smooth muscle cells: the response to hypoxia. Am J Physiol Lung Cell Mol Physiol. 280: L264-71.
11. Quinn DA, Honeyman TW, Joseph PM, Thompson BT, Hales CA, et al. (1991) Contribution of Na+/H+ exchange to pH regulation in pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 5: 586-91.
12. Neylon CB, Little PJ, Cragoe EJ Jr, Bobik A, (1990) Intracellular pH in human arterial smooth muscle. Regulation by Na+/H+ exchange and a novel 5-(N-ethyl-N-isopropyl)amiloride-sensitive Na+- and HCO3-dependent mechanism. Circ Res. 67: 814-25.
13. Rios EJ, Fallon M, Wang J, Shimoda LA, (2005) Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 289(5): L867-74.
14. Quinn DA, Du HK, Thompson BT, Hales CA, (1998) Amiloride analogs inhibit chronic hypoxic pulmonary hypertension. Am J Respir Crit Care Med. 157: 1263-8.
15. Yu L, Quinn DA, Garg HG, Hales CA, (2008) Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med. 177: 1276-84.
16. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T (1988) A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl. 6:S188-91.
17. Biswas P, Roy A, Gong R, Yango A, Tolbert E, et al. (2005) Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate. Am J Physiol Renal Physiol. 288: F8-15.
18. Raymond MN, Bole-Feysot C, Banno Y, Tanfin Z, Robin P, (2006) Endothelin-1 inhibits apoptosis through a sphingosine kinase 1-dependent mechanism in uterine leiomyoma ELT3 cells. Endocrinology. 147: 5873-82.
19. Kawanabe Y, Hashimoto N, Masaki T, (2002) Extracellular Ca2+ influx and endothelin-1-induced intracellular mitogenic cascades in rabbit internal carotid artery vascular smooth muscle cells. J Cardiovasc Pharmacol. 40: 307-14.
20. Mukherjee R, Apple KA, Squires CE, Kaplan BS, McLean JE, et al. (2006) Protein kinase C isoform activation and endothelin-1 mediated defects in myocyte contractility after cardioplegic arrest and reperfusion. Circulation. 114: I308-13.
21. Gallelli L, Pelaia G, D'Agostino B, Cuda G, Vatrella A, et al. (2005) Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ETA receptor-dependent activation of MAP kinases. J Cell Biochem. 96: 858-68.
22. Frasch HF, Marshall C, Marshall BE, (1999) Endothelin-1 is elevated in monocrotaline pulmonary hypertension. Am J Physiol. 1999 276: L304-10.
23. Galie N, Manes A, Branzi A, (2004) The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 61: 227-37.
24. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, et al. (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest. 120: 1562-9.
25. DiCarlo VS, Chen SJ, Meng QC, Durand J, Yano M, et al. (1995) ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol. 269: L690-7.
26. Nakanishi K, Tajima F, Nakata Y, Osada H, Tachibana S, et al. (1999) Expression of endothelin-1 in rats developing hypobaric hypoxia-induced pulmonary hypertension. Lab Invest. 79: 1347-57.
27. Bialecki RA, Fisher CS, Abbott BM, Barthlow HG, Caccese RG, et al. (1999) ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat. Pulm Pharmacol Ther. 12: 303-12.
28. Bonvallet ST, Zamora MR, Hasunuma K, Sato K, Hanasato N, et al. (1994) BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol. 266: H1327-31.
29. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R, (1992) Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 85: 504-9.
30. Stelzner TJ, O'Brien RF, Yanagisawa M, Sakurai T, Sato K, et al. (1992) Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol. 262: L614-20.
31. Stenmark KR, Rabinovitch M, (2010) Emerging therapies for the treatment of pulmonary hypertension. Pediatr Crit Care Med. 11: S85-90.
32. Lonchampt MO, Pinelis S, Goulin J, Chabrier PE, Braquet P, (1991) Proliferation and Na+/H+ exchange activation by endothelin in vascular smooth muscle cells. Am J Hypertens. 4: 776-9.
33. Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, et al. (2002) ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med. 165: 398-405.
34. Rodriguez-Vita J, Ruiz-Ortega M, Ruperez M, Esteban V, Sanchez-Lopez E, et al. (2005) Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells. Circ Res. 97: 125-34.
35. Hersch E, Huang J, Grider JR, Murthy KS, (2004) Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB. Am J Physiol Cell Physiol. 287: C1209-18.
36. Luscher TF, (1992) Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. Am Rev Respir Dis. 146: S56-60.
37. Luke T, Maylor J, Undem C, Sylvester JT, Shimoda LA, (2012) Kinase dependent activation of voltage-gated Ca2+ channels by ET-1 in pulmonary arterial myocytes during chronic hypoxia. Am J Physiol Lung Cell Mol Physiol. 302(10): L1128-39.
38. Lucchesi PA, Berk BC, (1995) Regulation of sodium-hydrogen exchange in vascular smooth muscle. Cardiovasc Res. 29: 172-7.
39. Berk BC, Taubman MB, Cragoe EJ Jr, Fenton JW 2nd, Griendling KK, (1990) Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and-independent pathways. J Biol Chem. 265: 17334-40.
40. Touyz RM, Schiffrin EL, (1997) Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways. Hypertension. 30: 1440-7.
41. Ebata S, Muto S, Okada K, Nemoto J, Amemiya M, et al. (1999) Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 56: 1400-12.
42. Koliakos G, Befani C, Paletas K, Kaloyianni M, (2007) Effect of endothelin on sodium/hydrogen exchanger activity of human monocytes and atherosclerosis-related functions. Ann N Y Acad Sci. 1095: 274-91.
43. Walter R, Helmle-Kolb C, Forgo J, Binswanger U, Murer H, (1995) Stimulation of Na+/H+ exchange activity by endothelin in opossum kidney cells. Pflugers Arch. 430: 137-44.
44. Guntupalli J, DuBose TD Jr, (1994) Effects of endothelin on rat renal proximal tubule Na+-Pi cotransport and Na+/H+ exchange. Am J Physiol. 266: F658-66.
45. Weigand LA, Sylvester JT, Shimoda LA, (2006) Mechanisms of Endothelin-1-Induced Contraction in Pulmonary Arteries from Chronically Hypoxic Rats. Am J Physiol Lung Cell Mol Physiol. 290: L284-L290.
46. Shimoda LA, Sylvester JT, Booth GM, Shimoda TH, Meeker S, et al. (2001) Inhibition of voltage-gated K+ currents by endothelin-1 in human pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol. 281: L1115-22.
47. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, et al. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem. 268: 9194-7.
48. Shimoda LA, Sylvester JT, Sham JS, (1998) Inhibition of voltage-gated K+ current in rat intrapulmonary arterial myocytes by endothelin-1. Am J Physiol. 274: L842-53.
49. Muto S, Ebata S, Okada K, Saito T, Asano Y, (2000) Glucocorticoid modulates Na+/H+ exchange activity in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 57: 2319-33.
50. Mitsuka M, Berk BC, (1991) Long-term regulation of Na+-H+ exchange in vascular smooth muscle cells: role of protein kinase C. Am J Physiol. 260: C562-9.
51. Danthuluri NR, Brock TA, (1990) Endothelin receptor-coupling mechanisms in vascular smooth muscle: a role for protein kinase C. J Pharmacol Exp Ther. 254: 393-9.
52. Hubel CA, Highsmith RF, (1995) Endothelin-induced changes in intracellular pH and Ca2+ in coronary smooth muscle: role of Na+-H+ exchange. Biochem J. 310 (Pt 3): 1013-20.
53. He JQ, Pi Y, Walker JW, Kamp TJ, (2000) Endothelin-1 and photoreleased diacylglycerol increase L-type Ca2+ current by activation of protein kinase C in rat ventricular myocytes. J Physiol. 524 Pt 3: 807-20.
54. Bouallegue A, Daou GB, Srivastava AK, (2007) Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol. 5: 45-52.
55. Ivey ME, Osman N, Little PJ, (2008) Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis. 199: 237-47.
56. Griendling KK, Tsuda T, Alexander RW, (1989) Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. J Biol Chem. 264: 8237-40.
57. Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T, (2006) Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci. 119: 1769-80.
58. Homma N, Nagaoka T, Morio Y, Ota H, Gebb SA, et al. (2007) Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. J Cardiovasc Pharmacol. 50: 697-702.
59. Yang X, Huang HC, Yin H, Alpern RJ, Preisig PA, (2007) RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3. Am J Physiol Renal Physiol. 293: F1054-64.
60. Tominaga T, Ishizaki T, Narumiya S, Barber DL, (1998) p160ROCK mediates RhoA activation of Na-H exchange. Embo J. 17: 4712-22.
61. Tominaga T, Barber DL, (1998) Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol Biol Cell. 9: 2287-303.
62. Janakidevi K, Fisher MA, Del Vecchio PJ, Tiruppathi C, Figge J, et al. (1992) Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol. 263: C1295-301.
63. Wedgwood S, Dettman RW, Black SM, (2001) ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol. 281: L1058-67.
64. Aversa CR, Oparil S, Caro J, Li H, Sun SD, et al. (1997) Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. Am J Physiol. 273: L848-55.
65. Elton TS, Oparil S, Taylor GR, Hicks PH, Yang RH, et al. (1992) Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol. 263: R1260-4.
66. Li H, Chen SJ, Chen YF, Meng QC, Durand J, et al. (1994) Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol. 77: 1451-9.
67. Li H, Elton TS, Chen YF, Oparil S, (1994) Increased endothelin receptor gene expression in hypoxic rat lung. Am J Physiol. 266: L553-60.
68. Chen SJ, Chen YF, Opgenorth TJ, Wessale JL, Meng QC, et al. (1997) The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J Cardiovasc Pharmacol. 29: 713-25.
69. Eddahibi S, Raffestin B, Clozel M, Levame M, Adnot S, (1995) Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol. 268: H828-35.
70. Stewart DJ, Levy RD, Cernacek P, Langleben D, (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 114: 464-9.